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I. Introduction (Heading 1) (bold, 11 pt) 
Dialysis is a therapy that aims to remove waste and excess fluid from the body. This method 
replaces the main function of the kidney. Two types of dialysis are known, namely Peritoneal 
Dialysis, and Hemodialysis. Patients with chronic kidney failure are faced with these two treatment 
options. Both types of dialysis therapy have a risk of complications during the treatment period. In 
patients with chronic kidney failure with CAPD (Continuous Ambulatory Peritoneal Dialysis) has 
the risk of infection (one of them is peritonitis), if it does not do the principle of hygiene and if it is 
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Dialysis is a therapy that aims to remove waste and excess fluid from 
the body. This method replaces the main function of the kidney. Two 
types of dialysis are known, namely Peritoneal Dialysis and 
Hemodialysis. Patients with chronic kidney failure are faced with 
these two treatment options. Both types of dialysis therapy have a 
risk of complications during the treatment period that can affect the 
quality of life of patients. The purpose of this study was to determine 
the differences in dialysis methods of patients with chronic kidney 
failure with CAPD (continuous ambulatory peritoneal dialysis) and 
hemodialysis in terms of kidney function (urea and creatinine). 
The research design used a cross-sectional comparative analytical 
research design. The independent variables were the action of 
hemodialysis and CAPD. The dependent variables were urea and 
creatinine. The study sample was patients with chronic kidney 
failure who underwent hemodialysis and CAPD at Saiful Anwar 
Hospital in Malang with 126 respondents using consecutive 
sampling technique. Data analyzed by Independent T-test ( = 0.05). 
The research instruments were laboratory urea and creatinine 
observation sheets. 
Respondents who received hemodialysis were 23 patients. The 
average value of  respondents who underwent HD was equal to 
(12.93 ± 4.53) mg / dL and the average value of urea could be 
obtained at (144.89 ± 44.73) mg / dL. Respondents who received 
CAPD actions amounted to 20 patients. The average value of 
respondents who underwent CAPD was equal to (10.32 ± 4.1) mg / 
dL and the average value of urea could be obtained at (104.18 ± 
48.2) mg / dL. There were no differences in kidney function in 
patients who received HD and CAPD (creatinine p value = 0.130; 
urea p value = 0.083). 
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not carried out according to schedule and dosage then the deterioration of kidney function will 
worsen and have an impact on the heart's performance. While complications that often occur in 
patients who undergo HD are hemodynamic disorders (Landry and Oliver, 2006). Blood pressure 
generally decreases by doing ultrafiltration (UF) or withdrawal of fluid during the hemodialysis 
process. Intradialytic hypotension occurs in 20-30% of patients who undergo regular HD (Tatsuya 
et al., 2004). Research on patients with regular HD performed in Denpasar, received an incidence 
of intradialytic hypotension of 19.6% (Agustriadi, 2009). 
The number of patients who remain alive with dialysis therapy in the United States continues 
to increase from year to year. In this country the mortality of patients with dialysis is close to 18% 
per year. This death is caused by cardiovascular disease and infections. The survival rate in patients 
using hemodialysis compared with peritoneal dialysis is almost the same, but the complications of 
the use of both types of methods have not done so much research. The existence of this study is 
expected to provide an overview of the different dialysis methods between hemodialysis and 
CAPD to the quality of life in patients. 
The purpose of this study was to determine differences in dialysis methods of patients with 
chronic kidney failure with CAPD (continuous ambulatory peritoneal dialysis) and hemodialysis in 
terms of kidney function (urea and creatinine).  
 
II. Method 
The research design uses a cross-sectional comparative analytical research design. The 
independent variable is the action of hemodialysis and CAPD. The dependent variable is urea and 
creatinine. The study sample was patients with chronic kidney failure who underwent hemodialysis 
and CAPD at Saiful Anwar Hospital in Malang with 43 respondents using consecutive sampling 
technique. Data analysis using Independent T-test ( = 0.05). The research instrument was in the 
form of urea and creatinine observation sheets. The study was conducted between August 13-16 
2018. 
 
III. Results and Discussion 
Demographic data of respondents with HD shows the highest sex of respondents, namely 
men with a number of 57 (54.81%) respondents, the level of education shows almost half, namely 
the level of senior secondary at 39 (37.5%) respondents. Judging from the marital status shows that 
most of them are married or still have a partner that is equal to 94 (90.38%) respondents, while 
seen from their jobs almost half of the respondents do not work that is equal to 41 (39.42%) 
respondents. From the results it can also be known that the respondents undergo HD, which is 
almost half of the respondents are in the range of 1-3 years, 40 (38.46%) respondents, the majority 
of respondents are in the final stage or 5, as many as 63 (6058%) and almost half of respondents 
having hypertensive comorbidities, which amounted to 34 (32.69%) respondents. 
While the demographic data of respondents with CAPD shows that the respondents' sexes 
are mostly men with a total of 14 (63.64%) respondents, the level of education shows mostly that is 
the level of senior secondary at 14 (63.64%) respondents. Judging from the marital status, most of 
them were married or still had partners, which amounted to 16 (72.73%) respondents, while seen 
from their jobs, half of the respondents did not work, which was 11 (50%) respondents. From the 
results it can also be known for the length of time the respondents underwent CAPD, that is, almost 
half of the respondents were in the range of 1-3 years and less than a year, namely 8 (36.36%) 
respondents, the majority of respondents were at the final stage or 5 namely 14 (63.64% ) 
respondents and almost half of respondents did not have comorbidities which amounted to 9 
(40.91%) respondents after that with hypertension of 7 (31.82) respondents. 
The average value of the respondents who underwent HD was equal to (12.93 ± 4.53) mg / 
dL and the average value of urea could be obtained (144.89 ± 44.73) mg / dL. While the average 
value of the respondents who underwent CAPD was equal to (10.32 ± 4.1) mg / dL. The average 
urea value can be obtained at (104.18 ± 48.2) mg / dL. 
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Table 1. Analysis of the independent sample T-test test for differences in kidney function in HD 
patients and CAPD 
 
Variable P value 
Kreatinin  0,130 
Ureum  0,083 
 
The results of the analysis showed P values of creatinine (0.130) and urea (0.083) above the value 
of α (0.05) which means accept H0, which means there is no difference in kidney function in 
patients who get HD and CAPD. 
 
Analyzing the differences in CAPD and Hemodialysis on the physiology of the kidneys (urea 
and creatinine) of patients during dialysis therapy. 
The results of the analysis obtained P value of creatinine (0.130) and urea (0.083) above the 
value of α (0.05) which was significantly accepted by H0, which means there was no significant 
difference in kidney function in patients who received HD and CAPD. This is because the two 
treatments show that the levels of urea and creatinine are increasing and not so far apart. However, 
clinically the average value of urea and creatinine in CAPD respondents is lower than the 
respondents who undergo HD. The results showed that the average value of the respondents who 
underwent CAPD was equal to (10.32 ± 4.1) mg / dL, while the average value of urea could be 
obtained (104.18 ± 48.2) mg / dL when compared with HD respondents the results showed creature 
mean values (12.93 ± 4.53) mg / dL, while the mean urea values were obtained (144.89 ± 44.73) 
mg / dL. The results of this study can be concluded that CAPD action can prevent the increase in 
urea and creatinine levels better than HD. 
Ureum is the largest nitrogen product that is excreted through the kidneys. Ureum comes 
from the metabolism of food proteins and endogenous proteins in the body. The kidneys function to 
maintain urea levels within normal limits in the blood. In healthy kidney conditions, the urea will 
be released from the body continuously through the process of filtration and excretion. This process 
will help maintain the balance of urea levels in the blood. The balance of urea levels is very 
necessary to maintain physical conditions in patients with kidney failure. Patients with chronic 
kidney failure often experience elevated blood urea levels. This increase is caused by impaired 
kidney function in filtering and removing urea from the blood. Increased urea will cause a variety 
of symptoms in the multisystem body called uremic syndrome. A collection of symptoms due to an 
increase in urea will aggravate the physical condition of patients with kidney failure, thereby 
reducing the quality of life of patients (Yamana, 2009). The level of urea, blood creatinine level is 
also one of the important indicators for determining kidney excretion function (Black & Hawk, 
2009) and affects the quality of life of patients with CRF who undergo hemodialysis therapy 
(Yamana, 2009). 
While Creatinine is the result of muscle cell metabolism which is excreted into the blood 
after doing activities. Creatinine comes from food and biosynthesis of various organs, especially 
the liver. A diet source absorbed through the intestine will be synthesized into creatine by the liver. 
Creatinine is then used for muscle cell metabolism. Muscle cell metabolism will constantly convert 
creatine to creatinine which diffuses out of muscle cells. Creatinine in the blood will be excreted by 
the kidneys through urine. Increased creatinine levels in the blood occur when the kidney excretion 
function has decreased. This is because most creatinine is removed through the kidneys and there is 
no reabsorption process in the kidneys to restore creatinine. Therefore creatinine is a blood 
chemical that is important for determining the glomerular filtration rate as an indicator of kidney 
excretion function (Wyss, 2000). 
Excess urea levels cause conditions of acidity in the blood to increase which causes a 
disruption of the acid base balance in the body. Patients often experience metabolic acidosis under 
severe uremia. Metabolic acidosis causes various symptoms such as rapid and shallow breathing 
even to a decrease in consciousness. In addition, increased levels of urea in the blood also cause 
systemic symptoms in various body systems. Uremia causes multi-system disorders including 
gastrointestinal, respiratory, nerve, and so on. In the digestive system, uremia causes an increase in 
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stomach acid production, resulting in symptoms of nausea, vomiting and anorexia. In the 
respiratory system, uremia causes complaints of shortness of breath, shallow and fast breathing. 
This is as part of the body's compensation for maintaining normal pH in the blood by increasing 
CO2 excretion through the lungs. 
Patients who are able to maintain urea levels within normal limits will show better physical 
health and general health perceptions than patients who fail to maintain normal urea levels. Urea 
levels can be maintained within normal limits by running a low-protein diet and routine hemodialis 
therapy. The duration and frequency of hemodialysis adjusted to the excretion needs of patients 
will maintain urea levels within normal limits. The diffusion and ultrafiltration processes that occur 
in the dialiser are able to transfer excess urea from the blood into the dialysate solution, so that 
after undergoing dialysis the patient's urea level can be lowered. The condition of patients with 
kidney failure who require using lifelong dialysis therapy requires the respondent to comply with 
all lifestyles that are in accordance with the conditions of kidney failure so that the quality of life 
increases. 
IV. Conclusion 
There were no differences in kidney function in patients who received HD and CAPD 
statistically but clinically different, namely urea and creatinine in CAPD respondents lower than 
HD respondents. 
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